tiprankstipranks

Salim Yazji Insider Profile

4 Followers
Salim Yazji, CMO at Oncternal Therapeutics, holds 128.63K shares in Oncternal Therapeutics (Ticker: ONCT).
tipranks
Salim Yazji

Salim Yazji
Oncternal Therapeutics (ONCT)
CMO

Ranked #45,907 out of 99,335 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+5.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$147K
100.00%
A breakdown of Salim Yazji's holdings

Insider Roles

Oncternal Therapeutics
(ONCT)
CMO
Roles that Salim Yazji holds in companies

Most Profitable Insider Trade

Stock:
Oncternal Therapeutics
(ONCT)
Rating:Informative Buy
Date:Apr 14, 2023 - Apr 14, 2024
Return:+50.40%
The most profitable trade made by Salim Yazji

Salim Yazji's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oncternal Therapeutics
Jan 05, 2024
CMO
Uninformative Sell
9.67K
$146.64K
Success Rate for
ONCT
1 out of 2 profitable transactions on
ONCT
50%
Average Return for
ONCT
Average return per transaction on
ONCT
+5.15%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jan 05, 2022
Uninformative Buy
$0.00
-
$0.00
Jan 31, 2022
Informative Buy
$16.90K
-
$1.69
-40.10%
Aug 01, 2022
Uninformative Buy
$0.00
-
$0.00
Apr 14, 2023
Informative Buy
$7.10K
-
$0.28
+50.40%
Jan 05, 2023
Uninformative Sell
$10.16K
-
$1.02
List of latest transactions for each holding click on a transaction to see Salim Yazji's performance on stock

Salim Yazji insider profile FAQ

What is the percentage of profitable transactions made by Salim Yazji?
The percentage of profitable transactions made by Salim Yazji is 50%.
    What is the average return per transaction made by Salim Yazji?
    The average return per transaction made by Salim Yazji is 5.10%.
      What stocks does Salim Yazji hold?
      Salim Yazji holds: ONCT stocks.
        What was Salim Yazji’s latest transaction?
        Salim Yazji latest transaction was an Uninformative Sell of $9.67K.
          What was Salim Yazji's most profitable transaction?
          Salim Yazji’s most profitable transaction was an Informative Buy of ONCT stock on April 14, 2023. The return on the trade was 50.40%.
            What is Salim Yazji's role in Oncternal Therapeutics?
            Salim Yazji's role in Oncternal Therapeutics is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.